Listed by the USPTO as HAUK TEODORO, PRICILA NMN
Tech Center 1600 • Art Units: 1617 1636 1645
This examiner grants 50% of resolved cases
HAUK TEODORO, PRICILA NMN is assigned to tech center 1600 and art unit 1617. The record contains 6 resolved cases, with an allowance rate of 50.0%, an interview lift of 0.0%, and a median of 906 days to allowance. The available record shows no measured interview lift.
The leading companies are University of Florida Research Foundation Inc., Boehringer Ingelheim International GmbH, and The Regents of the University of California. The associated firms are Brooks Kushman P.C., Casimir Jones, S.C., and FOLEY & LARDNER LLP. The small case history makes application-specific review more useful than relying on the aggregate figures.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19068745 | ACTIVE VACCINATION FOR THE TREATMENT OF NGF-RELATED DISORDERS | Non-Final OA | Boehringer Ingelheim Vetmedica GmbH |
| 18836272 | NOVEL LIVE MULTI-ANTIGENIC RECOMBINANT VACCINE AGAINST TUBERCULOSIS | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy50.0% of resolved applications examined by Pricila Nmn Hauk Teodoro were allowed (6 resolved cases), compared with 34.1% across Art Unit 1617 over the last five years.
This examiner's interview lift is +0.0 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Pricila Nmn Hauk Teodoro took 906 days on average from filing to allowance.
Pricila Nmn Hauk Teodoro examines applications in Art Unit 1617 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
